doi:10.3969/j.issn.1673-8640.2023.01.014

Abstract

CLC Number:

R446.11

Figures/Tables 8

References 17

[1]	BUTTARELLO M, MEZZAPELLE G, FREGUGLIA F, et al. Reticulated platelets and immature platelet fraction:clinical applications and method limitations[J]. Int J Lab Hematol, 2020, 42(4):363-370. DOI URL
[2]	PONS I, MONTEAGUDO M, LUCCHETTI G, et al. Correlation between immature platelet fraction and reticulated platelets. Usefulness in the etiology diagnosis of thrombocytopenia[J]. Eur J Haematol, 2010, 85(2):158-163. DOI PMID
[3]	WIEDMEIER S E, HENRY E, SOLA-VISNER M C, et al. Platelet reference ranges for neonates,defined using data from over 47 000 patients in a multihospital healthcare system[J]. J Perinatol, 2009, 29(2):130-136. DOI
[4]	Clinical and Laboratory Standards Institute. Defining, establishing, and verifying reference intervals in the clinical laboratory[S]. EP28-A3c,CLSI, 2010.
[5]	宋辉, 孔飞飞, 刘旋, 等. 网织血小板及其相关参数在儿童免疫性血小板减少症及脓毒症中的应用[J]. 检验医学, 2018, 33(7):626-628.
[6]	刘湘帆, HIDEO W, 胡翊群. 网织血小板的研究和应用[J]. 诊断学理论与实践, 2005, 4(6):505-506.
[7]	王丹微, 杨平, 沈瀚. 网织血小板检测在免疫因素相关的血小板减少性疾病中的诊断价值[J]. 国际检验医学杂志, 2017, 38(18):2611-2613.
[8]	JEON K, KIM M, LEE J, et al. Immature platelet fraction:a useful marker for identifying the cause of thrombocytopenia and predicting platelet recovery[J]. Medicine(Baltimore), 2020, 99(7):e19096.
[9]	PETERSON J A, MCFARLAND J G, CURTIS B R, et al. Neonatal alloimmune thrombocytopenia:pathogenesis,diagnosis and management[J]. Br J Haematol, 2013, 161(1):3-14. DOI URL
[10]	李囡, 王萍, 刘晓辉, 等. 北京地区健康成人及儿童未成熟血小板比率参考区间调查[J]. 中日友好医院学报, 2016, 30(2):84-86.
[11]	李国铎, 梁勤. 兰州地区健康人群网织血小板比率参考区间调查[J]. 国际检验医学杂志, 2017, 38(3):382-383.
[12]	李东杰, 张亚梅, 杜宗孝, 等. 银川地区健康成人网织血小板比率的参考区间研究[J]. 国际检验医学杂志, 2013, 34(Z):18-20.
[13]	SAXONHOUSE M A, SOLA M C, PASTOS K M, et al. Reticulated platelet percentages in term and preterm neonates[J]. J Pediatr Hematol Oncol, 2004, 26(12):797-802.
[14]	MACQUEEN B C, CHRISTENSEN R D, HENRY E, et al. The immature platelet fraction:creating neonatal reference intervals and using these to categorize neonatal thrombocytopenias[J]. J Perinatol, 2017, 37(7):834-838. DOI URL
[15]	IANNI B, MCDANIEL H, SAVILO E, et al. Defining normal healthy term newborn automated hematologic reference intervals at 24 hours of life[J]. Arch Pathol Lab Med, 2021, 145(1):66-74. DOI URL
[16]	KO Y J, KIM H, HUR M, et al. Establishment of reference interval for immature platelet fraction[J]. Int J Lab Hematol, 2013, 35(5):528-533. DOI PMID
[17]	JUNG H, JEON H K, KIM H J, et al. Immature platelet fraction:establishment of a reference interval and diagnostic measure for thrombocytopenia[J]. Korean J Lab Med, 2010, 30(5):451-459.

性别	例数	IPF%/%	IPF#/（×10⁹/L）
男	230	1.20（0.9~1.7）	3.77（2.85~5.25）
女	180	1.20（0.9~1.7）	4.17（2.99~5.31）
P值		0.794	0.346

性别	例数	IPF%/%	IPF#/（×10⁹/L）
男	230	1.20（0.9~1.7）	3.77（2.85~5.25）
女	180	1.20（0.9~1.7）	4.17（2.99~5.31）
P值		0.794	0.346

组别	例数	IPF%/%	IPF#/（×10⁹/L）
0~<1 d组	160	1.20（0.90~1.7）	4.06（2.92~5.33）
1~<2 d组	144	1.15（0.80~1.58）	3.78（2.77~5.24）
2~3 d组	106	1.25（0.9~1.73）	4.14（2.87~5.25）
P值		0.141	0.657

组别	例数	IPF%/%	IPF#/（×10⁹/L）
0~<1 d组	160	1.20（0.90~1.7）	4.06（2.92~5.33）
1~<2 d组	144	1.15（0.80~1.58）	3.78（2.77~5.24）
2~3 d组	106	1.25（0.9~1.73）	4.14（2.87~5.25）
P值		0.141	0.657

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 8

References 17

Related Articles 15

Recommended Articles

Metrics

[1]	DENG Chenxia, MEI Yanping, ZHANG Xia, HUANG Baoshan, TIAN Dan, CAO Mengting, HU Yongqi, LIN Yongping, TIAN Lijun. Depolymerization effect of optical platelet count on reversible platelet aggregation after blood collection [J]. Laboratory Medicine, 2023, 38(11): 1087-1090.
[2]	LU Tingyan, GU Danfeng, WANG Yahong, GE Yafang, YANG Haiou. Evaluation of vaginal secretion routine determination modes and review criteria analysis [J]. Laboratory Medicine, 2023, 38(11): 1091-1097.
[3]	. [J]. Laboratory Medicine, 2023, 38(11): 1098-1100.
[4]	. [J]. Laboratory Medicine, 2023, 38(10): 983-986.
[5]	. [J]. Laboratory Medicine, 2023, 38(9): 901-904.
[6]	. [J]. Laboratory Medicine, 2023, 38(9): 905-908.
[7]	CHENG Xu, YANG Cunqing, PANG Bo, GU Chun, HOU Xueyun, FEI Jiaxin, WU Min, LI Jun, LIU Guijian. Number and activity of peripheral blood eosinophils in obese people [J]. Laboratory Medicine, 2023, 38(9): 855-859.
[8]	LEI Jing, MAN Qiuhong, ZHAO Renjia, ZHANG Tiejun, JIANG Yanfeng, XU Kelin, SUO Chen, CHEN Xingdong. Elevated red blood cell distribution width increasing the risk of heart failure：a cohort study based on the UK Biobank [J]. Laboratory Medicine, 2023, 38(9): 860-864.
[9]	DUAN Lili, JIANG Chang, ZHOU Dongmei. Role of PLR in ankylosing spondylitis patients with positive antinuclear antibody [J]. Laboratory Medicine, 2023, 38(7): 669-674.
[10]	XIA Yanyan, XIA Yongquan, SONG Guanghao, XIA Mao. Role of coagulation-related monitoring indicators in the course of rivaroxaban anticoagulation for acute venous thromboembolism in elderly patients [J]. Laboratory Medicine, 2023, 38(5): 475-478.
[11]	CHEN Yi, WANG Jia, XU Zhiwei, ZHAI Yaping, XUAN Weixia. Effects of different anticoagulants on phagocytosis，activation and apoptosis of in vitro neutrophil function [J]. Laboratory Medicine, 2023, 38(5): 479-483.
[12]	YANG Liyuan, DAI Wanqin, WANG Xiaotong, LOU Xiaoli, WANG Yue, HOU Yanqiang. Effect of peripheral blood neutrophils on interferon-gamma release assay of Mycobacterium tuberculosis [J]. Laboratory Medicine, 2023, 38(5): 484-488.
[13]	. [J]. Laboratory Medicine, 2023, 38(5): 502-504.
[14]	XIE Yuan, YI Wanwan, SHI Qiuyuan, LÜ Zhongwei, LIU Jin. Clinical value of thromboelastography and conventional coagulation tests in evaluating coagulation status of colon cancer and colon polyps [J]. Laboratory Medicine, 2022, 37(11): 1007-1011.
[15]	MIAO Wenjia, GU Hao, LI Gang. Clinical application of maximum aggregation rate and thrombus maximum amplitude in children with Glanzmann thrombasthenia and Bernard-Soulier syndrome [J]. Laboratory Medicine, 2022, 37(11): 1026-1029.